<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35733060</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-4978</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Molecular biology reports</Title><ISOAbbreviation>Mol Biol Rep</ISOAbbreviation></Journal><ArticleTitle>A strong association between VEGF-A rs28357093 and amyotrophic lateral sclerosis: a brazilian genetic study.</ArticleTitle><Pagination><StartPage>9129</StartPage><EndPage>9133</EndPage><MedlinePgn>9129-9133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11033-022-07647-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that affects motor neurons and promotes progressive muscle atrophy. Vascular Endothelial Growth Factor A (VEGF-A) plays multiple roles in the central nervous systems (CNS). The purpose of this study was to evaluate the association between single nucleotide polymorphism (SNP) VEGF-A rs28357093 and ALS.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This case-control study was conducted in 101 ALS patients and 119 healthy individuals. Genotyping was performed by Polymerase Chain Reaction - Restriction Fragment Length Polymorphism (PCR-RFLP). The statistical analysis was carried out using the RStudio&#xae; and SNPStats&#xa9; software's. Analysis of genetic inheritance models was performed by logistic regression. Our findings demonstrated a strong association between VEGF- A rs28357093 and ALS in all genetic inheritance models, with a 9-fold increased risk for A/C - C/C genotypes (95%CI&#x2009;=&#x2009;3.70-21.88; p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The mutant allele was more frequent in ALS patients (p&#x2009;&lt;&#x2009;0.001) and this finding could be associated with ALS risk. This first study from the Brazilian central population was conducted to provide new insight into the pathogenesis of ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Caroline Christine Pincela</ForeName><Initials>CCP</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pathology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lima</LastName><ForeName>Nayane Soares</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pathology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Cruz Pereira Bento</LastName><ForeName>Dhiogo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pathology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Santos</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9480-4362</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Pathology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil. rdssantos@ufg.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil. rdssantos@ufg.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Reis</LastName><ForeName>Angela Adamski</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-8281-7334</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Pathology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil. angela@ufg.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Biological Sciences Institute (ICBII), Federal University of Goi&#xe1;s (UFG), Goi&#xe2;nia, Goi&#xe1;s, Brazil. angela@ufg.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Biol Rep</MedlineTA><NlmUniqueID>0403234</NlmUniqueID><ISSNLinking>0301-4851</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genetic polymorphisms</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Neurotrophic factor</Keyword><Keyword MajorTopicYN="N">Vascular alterations</Keyword><Keyword MajorTopicYN="N">Vascular endothelial growth factor A</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35733060</ArticleId><ArticleId IdType="doi">10.1007/s11033-022-07647-z</ArticleId><ArticleId IdType="pii">10.1007/s11033-022-07647-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prado LGR, Bicalho ICS, Vidigal-Lopes M, Ferreira CJA, Mageste-Barbosa LS, Gomez RS, De Souza LC, Teixeira AL (2016) Amyotrophic lateral sclerosis in Brazil: Case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener 17:282&#x2013;288</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17085</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27:1918&#x2013;1929</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D, Carmeliet P (2006) VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta 1762:1109&#x2013;1121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.04.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Pronto-Laborinho AC, Pinto S, de Carvalho M (2014) Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis. Biomed Res Int 2014</Citation></Reference><Reference><Citation>Lambrechts D, Poesen K, Fern&#xe1;ndez-Santiago R, Al-Chalabi A, Del Bo R, Van Vught PWJ, Khan S, Marklund SL, Brockington A, van Marion I, Anneser J, Shaw C, Ludolph AC, Leigh NP, Comi GP, Gasser T, Shaw PJ, Morrison KE, Andersen PM, Van den Berg LH, Thijs V, Siddique T, Robberecht W, Carmeliet P (2009) Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the &#x2013; 2578AA genotype. J Med Genet 46:840&#x2013;846</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2008.058222</ArticleId></ArticleIdList></Reference><Reference><Citation>Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N (2009) STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol 33:581&#x2013;598</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.20410</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt RCL, Ralph SA, Webb NJA, Watson CJ, Clark AGB, Mathieson PW, Brenchley PEC (2003) Steroid-sensitive nephrotic syndrome and vascular endothelial growth factor gene polymorphisms. Eur J Immunogenet 30:1&#x2013;3</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2370.2003.00360.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis AAS, Alc&#xe2;ntara KC, Farias DLC, dos Anjos LRB, Rodrigues DA, Pedrino GR, Santos RS (2019) The influence of MTHFR C677T polymorphism in chronic lymphocytic leukemia. Electrophoresis 40:1715&#x2013;1718</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.201800402</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ovidio F, Rooney JPK, Visser AE, Manera U, Beghi E, Logroscino G, Vermeulen RCH, Veldink JH, van den Berg LH, Hardiman O, Chi&#xf2; A, Euro (2019) Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study. J Neurol Neurosurg Psychiatry 90:11&#x2013;19-MOTOR consortium</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318559</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian L, Liu M, Cui L, Guan Y, Liu T, Cui B, Zhang K, Tai H, Shen D (2019) Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in China. J Clin Neurosci 66:12&#x2013;18</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2019.05.036</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong SW, Huisman MHB, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, Fischer K, Veldink JH, van den Berg LH (2012) Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol 176:233&#x2013;239</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws015</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PEC, Ray DW (2008) VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 49:3611&#x2013;3616</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.07-1383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383&#x2013;394</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange C, Storkebaum E, de Almod&#xf3;var CR, Dewerchin M, Carmeliet P (2016) Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12:439&#x2013;454</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.88</ArticleId></ArticleIdList></Reference><Reference><Citation>Salajegheh A, Smith RA, Kasem K, Gopalan V, Nassiri MR, William R, Lam AKY (2011) Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. Eur J Surg Oncol 37:93&#x2013;99</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2010.10.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YC, Peterson SE, Loring JF (2014) Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res 24:143&#x2013;160</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.151</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, Moreau C, Lassalle P, Perez T, De Seze J, Brunaud-Danel V, Dest&#xe9;e A, Tonnel AB, Just N (2004) Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology 62:2127&#x2013;2129</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000129913.44351.A3</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney JP, Gao L (2015) Proinflammatory Cytokines Increase Vascular Endothelial Growth Factor Expression in Alveolar Epithelial Cells. Mediators Inflamm 2015:387842</Citation></Reference><Reference><Citation>Proescholdt MA, Heiss JD, Walbridge S, M&#xfc;hlhauser J, Capogrossi MC, Oldfield EH, Merrill MJ (1999) Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 58:613&#x2013;627</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199906000-00006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten KG, Beers DR, Zhao W, Appel SH (2015) Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:364&#x2013;375</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0329-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla R, Rain M, Chawathey S, Modgil S, Tyagi R, Thakur K, Pannu V, Sharma SK, Anand A (2020) Identifying putative cerebrospinal fluid biomarkers of amyotrophic lateral sclerosis in a north Indian population. Muscle Nerve 62:528&#x2013;533</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Zhou S, Cai H, Gong Z, Zang D (2014) VEGF levels in CSF and serum in mild ALS patients. J Neurol Sci 346:216&#x2013;220</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.08.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta PK, Prabhakar S, Sharma S, Anand A (2011) Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation 8:47</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-47</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Cao C, Qin X-Y, Yu Y, Yuan J, Zhao Y, Cheng Y (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep 7:9094</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09097-1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>